← Eichor
Study identifier: NCT06913257 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Cost-Effectiveness of ESWT Plus Rehabilitation vs Rehabilitation Alone in Post-Burn Scars

Condition: Hypertrophic Scar  ·  Sponsor: Al Hayah University In Cairo

PhaseNA
Planned participants104
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This randomized controlled trial (RCT) will evaluate the cost-effectiveness of combining extracorporeal shock wave therapy (ESWT) with standard rehabilitation versus standard rehabilitation alone for the management of hypertrophic post-burn scars in adults. The study will assess clinical outcomes-such as pain intensity, pruritus, and scar quality-alongside economic outcomes including cost per quality-adjusted life year (QALY) gained, direct medical costs, and indirect costs (e.g., absenteeism and reduced productivity). Results will inform health policy and resource allocation decisions for advanced burn rehabilitation interventions.

This description comes directly from the study's public registry record.

Talk to the study team

Ibrahim Zoheiry, Ph.D  ·  01277774949  ·  ibrahim.alzoheiry@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Faculty of Physical Therapy, Al Hayah UniversityCairo, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06913257